Recurrence and survival predictive value of phenotypic expression of Bcl-2 varies with tumor stage of colorectal adenocarcinoma

Cancer Biomarkers

Volumn 1, Issue 4-5, 2005, Pages 241-250

  Chatla, Chakrapani ^a   Jhala, Nirag C ^a   Katkoori, Venkat R ^a   Alexander, Dominik ^b   Meleth, Sreelatha ^b   Grizzle, William E ^a   Manne, Upender ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

and prognosis; Bcl 2 expression; caucasians; Colorectal adenocarcinoma; recurrence; tumor stage

Indexed keywords

PROTEIN BCL 2; TUMOR MARKER;

ADENOCARCINOMA; AGED; ARTICLE; CANCER STAGING; COLORECTAL TUMOR; DIAGNOSTIC PROCEDURE; EVALUATION; FEMALE; HUMAN; KAPLAN MEIER METHOD; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOLOGY; PHENOTYPE; PREDICTION AND FORECASTING; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PHENOTYPE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 39049178523     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-2005-14-507     Document Type: Article

References (42)

1. American Cancer Society, Cancer facts and figures, Atlanta, GA., 2003, 1-52.
2. G., Nodal staging of colorectal carcinomas and sentinel nodes, J Clin Pathol 56(5) (2003), 327-335.
3. Efficacy of adjuvant fluorouracil and folinic acid in B2 colon cancer. International Multicentre Pooled Analysis of B2 Colon Cancer Trials (IMPACT B2) Investigators, J Clin Oncol 17(5) (1999), 1356-1363.
4. Mamounas, Wieand, Wolmark, Bear, Atkins, Song, Jones and Rockette, Comparative efficacy of adjuvant chemotherapy in patients with Dukes' B versus Dukes' C colon cancer: results from four National Surgical Adjuvant Breast and Bowel Project adjuvant studies (C-01, C-02, C-03, and C-04), J Clin Oncol 17(5) (1999), 1349-1355.
5. McDonald, Adjuvant therapy of colorectal cancer, CA Cancer J Clin 49 (1999), 202-219.
6. Bedi, Pasricha, Akhtar, Barber, Bedi, Giardiello, Zehnbauer, Hamilton and Jones, Inhibition of apoptosis during development of colorectal cancer, Cancer Res 55(9) (1995), 1811-1816.
7. Reed, Bcl-2 and the regulation of programmed cell death, J Cell Biol 124(1-2) (1994), 1-6.
8. Manne, Myers, Moron, Poczatek, Dillard, Weiss, Brown, Srivastava and Grizzle, Prognostic significance of Bcl-2 expression and p53 nuclear accumulation in colorectal adenocarcinoma, International Journal of Cancer 74(3) (1997), 346-358.
9. Manne,Weiss and Grizzle, Bcl-2 expression is associated with improved prognosis in patients with distal colorectal adenocarcinomas, Int J Cancer 89(5) (2000), 423-430.
10. Manne,Weiss, Myers, Danner, Moron, Srivastava and Grizzle, Nuclear accumulation of p53 in colorectal adenocarcinoma: prognostic importance differs with race and location of the tumor, Cancer 83 (1998), 2456-2467.
11. Grizzle, Manne,Weiss, Jhala and Talley, Molecular staging of colorectal cancer in African-American and Caucasian patients using phenotypic expression of p53, Bcl-2, MUC-1 AND p27(kip-1), Int J Cancer 97(4) (2002), 403-409.
12. Hoos, Nissan, Stojadinovic, Shia, Hedvat, Leung, Paty, Klimstra, Cordon-Cardo and Wong, Tissue microarray molecular profiling of early, node-negative adenocarcinoma of the rectum: a comprehensive analysis, Clin Cancer Res 8(12) (2002), 3841-3849.
13. Takanishi, Hart, Covarelli, Chappell and Michelassi, Ploidy as a prognostic feature in colonic adenocarcinoma, Arch Surg 131(6) (1996), 587-592.
14. Manne, Weiss and Grizzle, Racial differences in the prognostic usefulness of MUC1 and MUC2 in colorectal adenocarcinomas, Clinical Cancer Research 6 (2000), 4017-4025.
15. Ashktorab, Smoot, Carethers, Rahmanian, Kittles, Vosganian, Doura, Nidhiry, Naab, Momen, Shakhani and Giardiello, High incidence of microsatellite instability in colorectal cancer from African Americans, Clin Cancer Res 9(3) (2003), 1112-1117.
16. Manne, Jhala, Jones, Weiss, Chatla, Meleth, Suarez-Cuervo and Grizzle, Prognostic significance of p27(kip-1) expression in colorectal adenocarcinomas is associated with tumor stage, Clin Cancer Res 10(5) (2004), 1743-1752.
17. Alexander, Chatla, Funkhouser, Meleth, Grizzle and Manne, Postsurgical disparity in survival between African Americans and Caucasians with colonic adenocarcinoma, Cancer 101(1) (2004), 66-76.
18. Compton, Fielding, Burgart, Conley, Cooper, Hamilton, Hammond, Henson, Hutter, Nagle, Nielsen, Sargent, Taylor, Welton andWillett, Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999, Arch Pathol Lab Med 124(7) (2000), 979-994.
19. Green, Page, Fleming, Fritz, Balch, Haller and Morrow, American Joint Committee on Cancer, Cancer Staging Handbook from the AJCC Cancer Staging Manual., 6th, Springer, New York, 2002, 127-138.
20. World Health organization, International classification of diseases for oncology, (2nd ed.), Geneva: World Health Organization, 1990.
21. Manne, Myers, Srivastava and Grizzle, Loss of tumor markerimmunostaining intensity on stored paraffin slides of breast cancer, J Natl Cancer Inst 89 (1997), 585-586.
22. Fleiss, Statistical methods for rates and proportions, John Wiley and Sons, New York, NY, 1981.
23. Kaplan and Meier, Non-parametric estimation from incomplete observations, J Am Stat Assoc 53(457-481) (1958).
24. Cox, Regression models and life tables, J Roy Stat Soc 34 (1972), 187-220.
25. Allison, Survival Analysis Using the SAS System: A Practical Guide, SAS Institute Inc, Cary, NC, 1995.
26. Kleinbaum, Survival Analysis: A Self Learning Text, Springer-Verlag, New York, NY, 1996.
27. Kaklamanis, Savage, Whitehouse, Doussis-Anagnostopoulou, Biddolph, Tsiotos, Mortensen, Gatter and Harris, Bcl-2 protein expression: association with p53 and prognosis in colorectal cancer, Br J Cancer 77(11) (1998), 1864-1869.
28. Hague, Moorghen, Hicks, Chapman and Paraskeva, BCL-2 expression in human colorectal adenomas and carcinomas, Oncogene 9(11) (1994), 3367-3370.
29. Ofner, Riehemann, Maier, Riedmann, Nehoda, Totsch, Bocker, Jasani and Schmid, Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: correlation with tumour stage and patient survival, Br J Cancer 72(4) (1995), 981-985.
30. Sinicrope, Hart, Michelassi and Lee, Prognostic value of bcl-2 oncoprotein expression in stage II colon carcinoma, Clinical Cancer Research 1(10) (1995), 1103-1110.
31. Ilyas, Hao, Wilkinson, Tomlinson, Abbasi, Forbes, Bodmer and Talbot, Loss of Bcl-2 expression correlates with tumour recurrence in colorectal cancer, Gut 43(3) (1998), 383-387.
32. Schwandner, Schiedeck, Bruch, Duchrow, Windhoevel and Broll, p53 and Bcl-2 as significant predictors of recurrence and survival in rectal cancer, Eur J Cancer 36(3) (2000), 348-356.
33. Giatromanolaki, Sivridis, Stathopoulos, Fountzilas, Kalofonos, Tsamandas, Vrettou, Scopa, Polychronidis, Simopoulos and Koukourakis, Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse, Anticancer Res 21(1A) (2001), 253-259.
34. Rosati, Chiacchio, Reggiardo, De Sanctis and Manzione, Thymidylate synthase expression, p53, bcl-2, Ki-67 and p27 in colorectal cancer: relationships with tumor recurrence and survival, Tumour Biol 25(5-6) (2004), 258-263.
35. Liu, Liu, Fang and Men, Expression of bcl-2 protein in gastric carcinoma and its significance, World J Gastroenterol 4(3) (1998), 228-230.
36. Tjalma, De Cuyper, Weyler, Van Marck, De Pooter, Albertyn and van Dam, Expression of bcl-2 in invasive and in situ carcinoma of the uterine cervix, Am J Obstet Gynecol 178(1 Pt 1) (1998), 113-117.
37. Koide, Koike, Adachi, Amano, Usuda and Nagata, Immunohistochemical expression of bcl-2 protein in squamous cell carcinoma and basaloid carcinoma of the esophagus, Surg Today 27(8) (1997), 685-691.
38. Saegusa and Okayasu, Bcl-2 is closely correlated with favorable prognostic factors and inversely associated with p53 protein accumulation in endometrial carcinomas: immunohistochemical and polymerase chain reaction/loss of heterozygosity findings, J Cancer Res Clin Oncol 123(8) (1997), 429-434.
39. Deichman, Matveeva, Kashkina, Dyakova, Uvarova, Nikiforov and Gudkov, Cell transforming genes and tumor progression: in vivo unified secondary phenotypic cell changes, Int J Cancer 75(2) (1998), 277-283.
40. Vail, Pierce and Fausto, Bcl-2 delays and alters hepatic carcinogenesis induced by transforming growth factor alpha, Cancer Res 61(2) (2001), 594-601.
41. Popescu, Lohri, de Kant, Thiede, Reuter, Herrmann and Rochlitz, bcl-2 expression is reciprocal to p53 and c-myc expression in metastatic human colorectal cancer, Eur J Cancer 34(8) (1998), 1268-1273.
42. Gurova and Gudkov, Paradoxical role of apoptosis in tumor progression, J Cell Biochem 88(1) (2003), 128-137.